:max_bytes(133120)/d1qcnx2r3xkirq.cloudfront.net/popsci/popsci-rssapp-fiercepharma-com-e47c8ce9/ade8895ce552697ff6620af67ed6f4af_wm.png)
Fierce Pharma Asia—Merck’s PD-1xVEGF data; Zai Lab’s global view; Kailera’s record IPO
Summary: Big things are happening in the medical world! Merck shared early results for a new lung cancer drug, showing it helped 55% of patients. Meanwhile, Kailera Therapeutics, a company focused on weight-loss drugs, just raised a record-breaking $625 million to grow their business.
Other companies are making moves, too. Zai Lab is trying to expand globally, and a new startup named Tortugas launched with $106 million to treat brain conditions. A former FDA leader also suggested that countries should work together more to review new drugs. But it's not all good news—Samsung Biologics is making huge profits but is now facing a worker strike!
For more details, see rssapp-fiercepharma-com at fiercepharma.com/pharma/merck-pd-1vegf-data-zai-lab-global-view-kailera-record-ipo (opens in new tab)